EP2928462A4 - Verfahren zur verabreichung von zusammensetzungen mit docosapentaensäure - Google Patents

Verfahren zur verabreichung von zusammensetzungen mit docosapentaensäure

Info

Publication number: EP2928462A4
Authority: EP; European Patent Office
Prior art keywords: methods; docosapentaenoic acid; administering compositions; administering; compositions
Prior art date: 2012-12-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP13861305.4A

Other languages

English (en)

French (fr)

Other versions

EP2928462A2 (de

Inventor

George Bobotas

Abdel Aziz Fawzy

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Matinas Biopharma Inc

Original Assignee

Matinas Biopharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-12-06

Filing date

2013-12-06

Publication date

2016-06-01

2013-12-06 Application filed by Matinas Biopharma Inc filed Critical Matinas Biopharma Inc

2015-10-14 Publication of EP2928462A2 publication Critical patent/EP2928462A2/de

2016-06-01 Publication of EP2928462A4 publication Critical patent/EP2928462A4/de

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/06—Preservation of finished products
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B5/00—Preserving by using additives, e.g. anti-oxidants
- C11B5/0007—Organic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Oil, Petroleum & Natural Gas (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Obesity (AREA)
Hematology (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Botany (AREA)
Emergency Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Biotechnology (AREA)
Microbiology (AREA)

EP13861305.4A 2012-12-06 2013-12-06 Verfahren zur verabreichung von zusammensetzungen mit docosapentaensäure Withdrawn EP2928462A4 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201261734331P	2012-12-06	2012-12-06
US201361780948P	2013-03-13	2013-03-13
PCT/US2013/073714 WO2014089511A2 (en)	2012-12-06	2013-12-06	Methods of administering compositions comprising docosapentaenoic acid

Publications (2)

Publication Number	Publication Date
EP2928462A2 EP2928462A2 (de)	2015-10-14
EP2928462A4 true EP2928462A4 (de)	2016-06-01

Family

ID=50884050

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
EP13861305.4A Withdrawn EP2928462A4 (de)	2012-12-06	2013-12-06	Verfahren zur verabreichung von zusammensetzungen mit docosapentaensäure
EP13861394.8A Withdrawn EP2929041A4 (de)	2012-12-06	2013-12-06	Omega-3-pentaensäure-zusammensetzungen und verfahren zur verwendung
EP21170003.4A Withdrawn EP3888646A1 (de)	2012-12-06	2013-12-06	Omega-3-pentaensäure-zusammensetzungen und verfahren zur verwendung

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
EP13861394.8A Withdrawn EP2929041A4 (de)	2012-12-06	2013-12-06	Omega-3-pentaensäure-zusammensetzungen und verfahren zur verwendung
EP21170003.4A Withdrawn EP3888646A1 (de)	2012-12-06	2013-12-06	Omega-3-pentaensäure-zusammensetzungen und verfahren zur verwendung

Country Status (9)

Country	Link
EP (3)	EP2928462A4 (de)
JP (4)	JP6881893B2 (de)
KR (3)	KR20210059779A (de)
CN (4)	CN113274378A (de)
AU (7)	AU2013354969A1 (de)
CA (2)	CA2894366A1 (de)
IN (2)	IN2015DE05009A (de)
MX (2)	MX2015007082A (de)
WO (2)	WO2014089511A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101568665B1 (ko)	2015-07-21	2015-11-12	디와이오토 주식회사	모터의 맥동 전류를 증가시키는 브러시 구조
EP3475704A1 (de) *	2016-06-28	2019-05-01	Nestec S.A.	Biomarker der blut-hirn-schrankendysfunktion
JP2018168139A (ja) *	2016-10-21	2018-11-01	マルハニチロ株式会社	ｎ−３系不飽和脂肪酸を含む中性脂肪値の低減または上昇抑制用の組成物、並びに該組成物の製造におけるｎ−３系不飽和脂肪酸の使用
JP7099821B2 (ja) *	2017-12-20	2022-07-12	ポッカサッポロフード＆ビバレッジ株式会社	Ｐｃｓｋ９阻害剤及びコレステロール代謝改善用食品組成物
EP3586640A1 (de)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Dha-angereicherte mehrfach ungesättigte fettsäurezusammensetzungen

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1714564A1 (de) *	2005-04-21	2006-10-25	N.V. Nutricia	Verfahren zur Behandlung oder Vorbehandlung von Lungeninsuffiziens
WO2008032949A1 (en) *	2006-09-14	2008-03-20	Ilshin Wells Co., Ltd.	Glyceride oil composition from fish oil and preparation method thereof
US20110071090A1 (en) *	2009-03-11	2011-03-24	Stable Solutions Llc	Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
WO2013192109A1 (en) *	2012-06-17	2013-12-27	Matinas Biopharma, Inc.	Omega-3 pentaenoic acid compositions and methods of use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8819110D0 (en)	1988-08-11	1988-09-14	Norsk Hydro As	Antihypertensive drug & method for production
GB9901809D0 (en) *	1999-01-27	1999-03-17	Scarista Limited	Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
GB0016045D0 (en)	2000-06-29	2000-08-23	Laxdale Limited	Therapeutic combinations of fatty acids
JP2002125618A (ja) *	2000-10-30	2002-05-08	Katsuyuki Wakatsuki	健康食品
WO2007058523A1 (en)	2005-11-17	2007-05-24	N.V. Nutricia	Composition with docosapentaenoic acid
AU2007270135B9 (en) *	2006-07-05	2013-06-27	Fermentalg	Production of ultrapure EPA and polar lipids from largely heterotrophic culture
EP2405903B1 (de) *	2009-03-09	2024-04-10	Basf As	Zusammensetzungen mit einer fettsäure-öl-mischung und einer freien fettsäure sowie verfahren dafür und verwendungen davon
US8241672B2 (en) *	2009-03-11	2012-08-14	Stable Solutions Llc	Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
AU2010241571B2 (en) *	2009-04-29	2014-06-26	Amarin Pharmaceuticals Ireland Limited	Stable pharmaceutical composition and methods of using same
CA3129996A1 (en) *	2009-06-15	2010-12-23	Amarin Pharmaceuticals Ireland Limited	Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
CA2827585A1 (en) *	2011-02-16	2012-08-23	Pivotal Therapeutics, Inc.	Statin and omega 3 fatty acids (epa, dha and dpa) for use in cardiovascular diseases
EP2675442A1 (de) *	2011-02-16	2013-12-25	Pivotal Therapeutics, Inc.	Cholesterinabsorptionsinhibitor (azetidinon) und omega-3-fettsäuren (epa, dha, dpa) zur senkung des cholesterinspiegels und zur reduktion von kardiovaskulären ereignissen

2013
- 2013-12-06 AU AU2013354969A patent/AU2013354969A1/en not_active Abandoned
- 2013-12-06 EP EP13861305.4A patent/EP2928462A4/de not_active Withdrawn
- 2013-12-06 AU AU2013354979A patent/AU2013354979A1/en not_active Abandoned
- 2013-12-06 KR KR1020217013255A patent/KR20210059779A/ko active IP Right Grant
- 2013-12-06 JP JP2015545894A patent/JP6881893B2/ja active Active
- 2013-12-06 CA CA2894366A patent/CA2894366A1/en not_active Abandoned
- 2013-12-06 WO PCT/US2013/073714 patent/WO2014089511A2/en active Application Filing
- 2013-12-06 JP JP2015545896A patent/JP2016501249A/ja active Pending
- 2013-12-06 KR KR1020157017202A patent/KR20150103009A/ko not_active Application Discontinuation
- 2013-12-06 KR KR1020157016331A patent/KR20150103671A/ko not_active Application Discontinuation
- 2013-12-06 MX MX2015007082A patent/MX2015007082A/es unknown
- 2013-12-06 EP EP13861394.8A patent/EP2929041A4/de not_active Withdrawn
- 2013-12-06 CN CN202110585483.6A patent/CN113274378A/zh active Pending
- 2013-12-06 CA CA2894183A patent/CA2894183A1/en not_active Abandoned
- 2013-12-06 WO PCT/US2013/073701 patent/WO2014089501A1/en active Application Filing
- 2013-12-06 CN CN201380064003.5A patent/CN104902888A/zh active Pending
- 2013-12-06 EP EP21170003.4A patent/EP3888646A1/de not_active Withdrawn
- 2013-12-06 MX MX2015007085A patent/MX2015007085A/es unknown
- 2013-12-06 CN CN201380063980.3A patent/CN104937103A/zh active Pending
- 2013-12-06 CN CN202010984870.2A patent/CN112107570A/zh active Pending
2015
- 2015-06-10 IN IN5009DE2015 patent/IN2015DE05009A/xx unknown
- 2015-06-10 IN IN1505MU2015 patent/IN2015MU01505A/xx unknown
2017
- 2017-09-22 AU AU2017232203A patent/AU2017232203A1/en not_active Abandoned
2018
- 2018-09-12 AU AU2018229440A patent/AU2018229440A1/en not_active Abandoned
2019
- 2019-06-20 JP JP2019114492A patent/JP2019172697A/ja active Pending
- 2019-08-14 AU AU2019216634A patent/AU2019216634A1/en not_active Abandoned
2020
- 2020-06-03 AU AU2020203658A patent/AU2020203658A1/en not_active Abandoned
2021
- 2021-03-24 AU AU2021201865A patent/AU2021201865A1/en not_active Abandoned
- 2021-05-19 JP JP2021084578A patent/JP2021120407A/ja active Pending

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1714564A1 (de) *	2005-04-21	2006-10-25	N.V. Nutricia	Verfahren zur Behandlung oder Vorbehandlung von Lungeninsuffiziens
WO2008032949A1 (en) *	2006-09-14	2008-03-20	Ilshin Wells Co., Ltd.	Glyceride oil composition from fish oil and preparation method thereof
US20110071090A1 (en) *	2009-03-11	2011-03-24	Stable Solutions Llc	Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
WO2013192109A1 (en) *	2012-06-17	2013-12-27	Matinas Biopharma, Inc.	Omega-3 pentaenoic acid compositions and methods of use

Also Published As

Publication number	Publication date
KR20210059779A (ko)	2021-05-25
CN112107570A (zh)	2020-12-22
AU2018229440A1 (en)	2018-10-04
CN104902888A (zh)	2015-09-09
EP2929041A4 (de)	2016-06-08
MX2015007082A (es)	2016-01-12
CN104937103A (zh)	2015-09-23
IN2015MU01505A (de)	2016-05-27
AU2019216634A1 (en)	2019-09-05
MX2015007085A (es)	2016-01-12
KR20150103671A (ko)	2015-09-11
AU2020203658A1 (en)	2020-06-25
AU2013354969A1 (en)	2015-06-11
EP3888646A1 (de)	2021-10-06
JP2016501248A (ja)	2016-01-18
AU2013354979A1 (en)	2015-06-11
CA2894183A1 (en)	2014-06-12
JP6881893B2 (ja)	2021-06-02
JP2019172697A (ja)	2019-10-10
EP2929041A1 (de)	2015-10-14
WO2014089511A3 (en)	2014-07-31
WO2014089501A1 (en)	2014-06-12
KR20150103009A (ko)	2015-09-09
WO2014089511A2 (en)	2014-06-12
CN113274378A (zh)	2021-08-20
EP2928462A2 (de)	2015-10-14
CA2894366A1 (en)	2014-06-12
AU2017232203A1 (en)	2017-10-12
JP2021120407A (ja)	2021-08-19
JP2016501249A (ja)	2016-01-18
AU2021201865A1 (en)	2021-04-22
IN2015DE05009A (de)	2015-12-18

Legal Events

Date	Code	Title	Description
2015-09-11	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2015-10-14	17P	Request for examination filed	Effective date: 20150602
2015-10-14	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2015-10-14	AX	Request for extension of the european patent	Extension state: BA ME
2016-03-16	DAX	Request for extension of the european patent (deleted)
2016-06-01	A4	Supplementary search report drawn up and despatched	Effective date: 20160504
2016-06-01	RIC1	Information provided on ipc code assigned before grant	Ipc: C11B 5/00 20060101ALI20160428BHEP Ipc: A61K 31/225 20060101AFI20160428BHEP Ipc: A23D 9/00 20060101ALI20160428BHEP Ipc: A61K 9/48 20060101ALI20160428BHEP Ipc: A61K 31/202 20060101ALI20160428BHEP Ipc: A23D 9/06 20060101ALI20160428BHEP Ipc: A61K 31/40 20060101ALI20160428BHEP
2020-04-28	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2020-06-03	17Q	First examination report despatched	Effective date: 20200504
2020-11-13	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2022-10-21	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2022-11-23	18D	Application deemed to be withdrawn	Effective date: 20220701

Publication	Publication Date	Title
ZA201703992B (en)	2019-12-18	Inhalable pharmaceutical compositions
HK1212701A1 (zh)	2016-06-17	恩雜魯胺製劑
EP2861227A4 (de)	2016-01-27	Omega-3 pentaensäurezusammensetzungen und verfahren zur verwendung
SI2854768T1 (sl)	2017-08-31	Farmacevtski sestavki pemetrekseda
SG11201503646TA (en)	2015-07-30	Esterification of 2,5-furan-dicarboxylic acid
HK1198515A1 (en)	2015-05-15	Fatty acid compositions
HK1206596A1 (en)	2016-01-15	Pharmaceutical compositions comprising fatty acid esters
HK1206279A1 (en)	2016-01-08	Pharmaceutical compositions comprising glycerol esters
EP2917314A4 (de)	2016-06-29	Oligomeratzusammensetzung
IL237139A0 (en)	2015-04-30	Pharmaceutical compositions of memantine
PT2934134T (pt)	2019-12-03	Utilizações de inalação de ácido acetilsalicílico
PL2887924T3 (pl)	2017-09-29	Kompozycje farmaceutyczne etorykoksybu
IL236312A0 (en)	2015-02-26	Preparation of 18f-flucyclobin
HK1202053A1 (en)	2015-09-18	Treatment of liver conditions
EP2928462A4 (de)	2016-06-01	Verfahren zur verabreichung von zusammensetzungen mit docosapentaensäure
EP2867199A4 (de)	2015-12-02	Stabile zusammensetzungen aus fesoterodin
EP2938431A4 (de)	2016-08-31	Herstellung einer aluminiumoxid-silikazusammensetzung
ZA201401599B (en)	2015-08-26	Preparation of methacrylic acid
HK1216843A1 (zh)	2016-12-09	用於施用奧昔布寧的方法和組合物
EP2884964A4 (de)	2016-01-06	Pharmazeutische zusammensetzung von propofol
IL237221A (en)	2017-09-28	Preparations containing analogues of phospholipid drugs
IL233740A0 (en)	2014-09-30	Treatment of liver diseases
GB201202497D0 (en)	2012-03-28	Medicinal applications of substituted hydroxytetronic acids